Inventor · disambiguated record
Hanbiao Yang
Also filed as: YANG HANBIAO
28 granted patents·6 pending applications·308 citations·filing 2003–2022
96Inventor score
Files withPELOTON THERAPEUTICS INC163 V BIOSCIENCES INC8ROCHE PALO ALTO LLC3SMITHKLINE BEECHAM CORP3Roche Palo Alto2
Top patents by PatentIndex Score
34 records- 0197US7902197B2Pyrrolopyrazine kinase inhibitorsROCHE PALO ALTO LLC·Filed 2009·Granted Mar 8, 2011·106 cites·23 claims
- 0296US9796697B2Tricyclic inhibitors of HIF-2-alpha and uses thereofPELOTON THERAPEUTICS INC·Filed 2016·Granted Oct 24, 2017·18 cites·18 claims
- 0395US10155726B2Substituted pyridines and uses thereofPELOTON THERAPEUTICS INC·Filed 2016·Granted Dec 18, 2018·14 cites·24 claims
- 0495US7939531B2Pyrrolopyrazine kinase inhibitorsRoche Palo Alto·Filed 2009·Granted May 10, 2011·61 cites·32 claims
- 0593USRE49948EAryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2022·Granted Apr 30, 2024·1 cites·25 claims
- 0693US10144711B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2017·Granted Dec 4, 2018·8 cites·20 claims
- 0793US9908845B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2014·Granted Mar 6, 2018·16 cites·28 claims
- 0893US9896418B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2017·Granted Feb 20, 2018·9 cites·20 claims
- 0992US11591355B2CD73 inhibitors and uses thereofPELOTON THERAPEUTICS INC·Filed 2021·Granted Feb 28, 2023·2 cites·25 claims
- 1092US9969689B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2017·Granted May 15, 2018·8 cites·20 claims
- 1191US9809591B2Heterocyclic modulators of lipid synthesis3-V BIOSCIENCES INC·Filed 2015·Granted Nov 7, 2017·5 cites·10 claims
- 1291US8871790B2Heterocyclic modulators of lipid synthesisOSLOB JOHAN D·Filed 2012·Granted Oct 28, 2014·16 cites·21 claims
- 1389US10597366B2Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2018·Granted Mar 24, 2020·4 cites·18 claims
- 1487US9624173B2Heterocyclic modulators of lipid synthesis3-V BIOSCIENCES INC·Filed 2015·Granted Apr 18, 2017·5 cites·19 claims
- 1586US9884843B2Cyclic sulfone and sulfoximine analogs and uses thereofPELOTON THERAPEUTICS INC·Filed 2014·Granted Feb 6, 2018·9 cites·28 claims
- 1685US10118913B2Heterocyclic modulators of lipid synthesis3 V BIOSCIENCES INC·Filed 2018·Granted Nov 6, 2018·4 cites·20 claims
- 1785US9428502B2Heterocyclic modulators of lipid synthesis3-V BIOSCIENCES INC·Filed 2014·Granted Aug 30, 2016·7 cites·22 claims
- 1882US10053450B2Heterocyclic modulators of lipid synthesis3 V BIOSCIENCES INC·Filed 2016·Granted Aug 21, 2018·3 cites·33 claims
- 1981US10807948B2Aromatic compounds and uses thereofPELOTON THERAPEUTICS INC·Filed 2016·Granted Oct 20, 2020·2 cites·18 claims
- 2080US10189822B2Heterocyclic modulators of lipid synthesis3 V BIOSCIENCES INC·Filed 2016·Granted Jan 29, 2019·4 cites·13 claims
- 2177US8008298B2Pyrrolopyrazine kinase inhibitorsRoche Palo Alto·Filed 2009·Granted Aug 30, 2011·3 cites·42 claims
- 2272US2020190031A1Aryl ethers and uses thereofPELOTON THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2368US7271172B2Pyrrolidine and azetidine compounds as CCR5 antagonistsSMITHKLINE BEECHAM CORP·Filed 2003·Granted Sep 18, 2007·3 cites·12 claims
- 2465US7589204B2Indane compounds as CCR5 antagonistsSMITHKLINE BEECHAM CORP·Filed 2009·Granted Sep 15, 2009·0 cites·1 claims
- 2563US2014322355A1Heterocyclic modulators of lipid synthesis3 V BIOSCIENCES INC·Filed 2014·Application pending·0 cites
- 2660US2019015377A1Compositions for Use in Treating Pulmonary Arterial HypertensionPELOTON THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2756US2020115404A1Cd73 inhibitors and uses thereofPELOTON THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2855US7531661B2Indane compounds as CCR5 antagonistsSMITHKLINE BEECHAM CORP·Filed 2003·Granted May 12, 2009·0 cites·1 claims
- 2955US2009281133A1Heterocyclic antiviral compoundsROCHE PALO ALTO LLC·Filed 2009·Application pending·0 cites
- 3046US2009093501A1Heterocyclic antiviral compoundsROCHE PALO ALTO LLC·Filed 2008·Application pending·0 cites
- 3145US10226449B2Heterocyclic modulators of lipid synthesis and combinations thereof3 V BIOSCIENCES INC·Filed 2014·Granted Mar 12, 2019·0 cites·18 claims
- 3240US12331068B2Compositions and methods for inhibiting CD73PELOTON THERAPEUTICS INC·Filed 2019·Granted Jun 17, 2025·0 cites·20 claims
- 3335US10040767B2Benzimidazole derivatives and uses thereofPELOTON THERAPEUTICS INC·Filed 2015·Granted Aug 7, 2018·0 cites·23 claims
- 3431US8318764B2Macrocyclic inhibitors of JAKJAHANGIR ALAM·Filed 2010·Granted Nov 27, 2012·0 cites·30 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →